The American Society of Hematology (ASH) is committed to a transparent guideline development process that incorporates a diverse range of perspectives. Open comment periods engage stakeholders in the guideline development process in a transparent and comprehensive way, thereby strengthening the content and credibility of the final clinical practice guidelines.
Anyone is welcome to comment on draft recommendations, including ASH members, non-member physicians and researchers, allied professionals, representatives of industry and insurance companies, patients, caregivers, and members of the public.
How to Provide Comments
ASH only accepts responses to draft recommendations via online surveys, which are intended to collect quantitative and qualitative feedback that is useful for the guideline panel and for ASH.
By downloading the draft recommendations, participants agree to adhere to the following terms of the open comment period:
back to top
- The content of the draft recommendations is copyright of the sponsoring organization(s) and shall not be published or distributed by any other individual or organization.
- The content available for public comment is in draft form and is not for use in clinical practice or any other context. ASH will have no liability resulting from the use of the draft content or the information contained therein.
ASH guidelines are based on a systematic review of available evidence. Through a structured process, a guideline panel makes judgments about the evidence and forms recommendations. The guideline panel includes clinical and methodological experts as well as patient representatives.
The public comment period occurs after recommendations are formed but before a manuscript report of the guidelines has been finalized and before ASH organizational approval of the guidelines. Comments collected during the open comment period are provided to the guideline panel for review prior to finalizing the guidelines. Comments are also considered during multiple steps that follow, including ASH organizational approval of the guidelines, peer review of the guidelines for journal publication, implementation and dissemination efforts following publication, and future revision of the guidelines.
ASH guidelines are developed in accordance with the recommendations outlined in the Institute of Medicine’s Clinical Practice Guidelines We Can Trust.
Learn more about ASH's clinical practice guidelines.back to top
Submit Recommendations on Acute Myeloid Leukemia in Older Adults
The comment period for these DRAFT recommendations ends December 20, 2019.
If you have general comments or would like to comment on a specific question without completing the survey, please email firstname.lastname@example.org.
View the DRAFT Recommendation Text Submit commentsback to top
Sign Up for UpdatesSubmit your email address to be notified of upcoming opportunities for public comment.back to top
Please contact email@example.com
with inquiries related to the public comment period.
back to top